DHODH and familial pancreatic carcinoma: As gemcitabine treatment leads to increased de novo pyrimidine synthesis in pancreatic cancer cells, combination of DHODH inhibitor Ter with gemcitabine reversed gemcitabine-induced nucleoside synthesis and thus exhibits synergistic effect against pancreatic cancer proliferation [82].